Sargent Investment Group, LLC Bristol Myers Squibb CO Transaction History
Sargent Investment Group, LLC
- $620 Million
- Q1 2025
A detailed history of Sargent Investment Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sargent Investment Group, LLC holds 19,738 shares of BMY stock, worth $918,803. This represents 0.19% of its overall portfolio holdings.
Number of Shares
19,738
Previous 17,656
11.79%
Holding current value
$918,803
Previous $998,000
20.54%
% of portfolio
0.19%
Previous 0.16%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,662Shares Held
1.63BCall Options Held
24.8MPut Options Held
23.4M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...